Search Orphan Drug Designations and Approvals
-
Generic Name: | venetoclax |
---|---|
Date Designated: | 03/27/2014 |
Orphan Designation: | Treatment of diffuse large B-cell lymphoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AbbVie Research and Development 1 North Waukegan Road North Chicago, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-